ESO Masterclass in Cancer Patient Advocacy
INCA has had the pleasure of participating in the 2nd Masterclass in Cancer Patient Advocacy: Working Towards Stronger and More Effective Advocacy in Europe, taking place on 24-26 June in Milan, Italy. INCA shares best practice Evidence-based activism at the 2nd...
Quality of life – Survey
Results from the survey “Quality-of-life”, patients with neuroendocrine tumors (NET)1. The survey gathered information on the NET patient experience, including diagnosis, disease impact and management, quality of life, and knowledge and awareness levels. ...
Quality of life – at ENETS
Results from the global survey “Quality-of-life”, patients with neuroendocrine tumors (NET)1. Presented at ENETS, European Neuroendocrine Tumor Society, in Barcelona. NET Cancer patient experience, including diagnosis, disease impact and management, quality of...
Global NET patient survey
The International Neuroendocrine Cancer Alliance (INCA) and Novartis presents the quality-of-life results from the first global survey of patients with neuroendocrine tumors (NETs), a rare type of cancer1. Nearly 2,000 patients from 12 countries completed the survey,...
INCA is a non-profit 501(c)3 organization incorporated in 2013.
